Crossmark

HAS2-AS1 is a novel LH/hCG target gene regulating HAS2 expression and enhancing cumulus cells migration

Crossref DOI link: https://doi.org/10.1186/s13048-019-0495-3

Published Online: 2019-02-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yung, Yuval https://orcid.org/0000-0001-5873-7652
Ophir, Libby

Yerushalmi, Gil M.

Baum, Micha

Hourvitz, Ariel

Maman, Ettie
Funding

Funding for this research was provided by:

Ministry of Health, Israel (3-00000-7410)

Chaim Sheba Medical Center (05/2014)
License Information

Text and Data Mining valid from 2019-02-28
More Information

Article History

Received: 17 December 2018

Accepted: 18 February 2019

First Online: 28 February 2019

Ethics approval and consent to participate

: The study was approved by the local Institutional Review Board (IRB) committee of Chaim Sheba Medical Center, Tel Hashomer (ethical approval number SMC-11-8707 and SMC-12-9342). Written informed consent was obtained from each patient who provided samples.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.